TabletsClinical Overview
Hyoscine Butylbromide (10mg) and Mefenamic Acid (250mg) Tablets combines a quaternary ammonium antimuscarinic antispasmodic with an NSAID analgesic. Hyoscine butylbromide exerts localized antispasmodic activity on gastrointestinal, biliary, and genitourinary smooth muscle without central sedation, while mefenamic acid inhibits prostaglandin synthesis. Indicated for severe spasmodic dysmenorrhea, acute abdominal colic, and renal colic.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with food or milk, 1 tablet three times daily as needed. Swallow whole with water.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Dry mouth, nausea, heartburn, constipation, mild tachycardia, dizziness. Rare/Severe: Peptic ulceration, GI bleeding, urinary retention, and bronchospasm in aspirin-sensitive patients.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in active peptic ulcer, narrow-angle glaucoma, myasthenia gravis, mechanical intestinal obstruction, and severe renal failure.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.
Hyoscine Butylbromide Tablets 10 mg
Hyoscine Butylbromide Tablets (10mg) is a peripheral antimuscarinic antispasmodic on the WHO Model List of Essential Medicines. As a quaternary ammonium derivative, it does not cross the blood-brain barrier, exerting potent localized smooth muscle relaxant effects on the gastrointestinal tract, biliary tree, and urinary system without central anticholinergic adverse effects. Indicated for acute abdominal cramps, irritable bowel syndrome spasms, and spastic dysmenorrhea.
Tranexamic Acid 500mg + Mefenamic Acid 250mg Tablets
Tranexamic Acid 500mg + Mefenamic Acid 250mg Tablets is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Dicyclomine Hydrochloride 10mg + Mefenamic Acid 250mg Tablets
Dicyclomine Hydrochloride (10mg) and Mefenamic Acid (250mg) Tablets is a fixed-dose antispasmodic and fenamate NSAID combination. Dicyclomine relieves visceral smooth muscle spasms via antimuscarinic action and direct musculotropic relaxation; mefenamic acid inhibits cyclooxygenase and antagonizes prostaglandin receptors, eliminating pelvic pain and cramping. Indicated for severe spasmodic dysmenorrhea, intestinal colic, and spastic abdominal pain.
Rabeprazole 20mg (Enteric Coated) + Levosulpiride 75mg (Sustained Release) Capsules
Rabeprazole Sodium (20mg enteric-coated) and Levosulpiride (75mg sustained-release) combines a fast-acting proton pump inhibitor with a prokinetic and psychotropic benzamide. Rabeprazole rapidly suppresses gastric acid output, while levosulpiride selectively blocks dopamine D2 receptors and activates 5-HT4 receptors in the gastrointestinal tract, stimulating gastroduodenal motility and improving visceral hypersensitivity. Indicated for severe GERD, reflux esophagitis with delayed gastric emptying, non-ulcer dyspepsia, and gastroparesis.